Shopify Upgraded to ‘Outperform’ on Promising Growth Outlookby Mark Eisenberg 22.06.2024"Shopify retains Outperform rating from Oppenheimer, signaling robust growth with strong merchant additions and strategic investments for 2024."
Levi Strauss Maintains Buy Rating Amid Positive Market Sentimentby Mark Eisenberg 22.06.2024Levi Strauss stock holds a Buy rating from UBS at a $25 target. Stable investor sentiment, strategic growth moves, and ...
Consensys Predicts Ethereum ETF Approval Within Daysby John Darbie 22.06.2024Consensys predicts SEC will approve spot Ethereum ETF registrations within days, potentially boosting Ethereum's market outlook.
Dave & Buster’s Shareholders Approve Executive Pay, Re-elect Directorsby Mark Eisenberg 22.06.2024Dave & Buster's shareholders re-elected board members, approved executive pay, and retained KPMG. Despite financial challenges, the outlook remains positive.
EU-China Trade Tensions Escalate Amid German Talksby Mark Eisenberg 22.06.2024"Germany's minister Robert Habeck visits China amid EU-China trade tensions over EV tariffs, seeking dialogue to prevent a trade war."
Cooper Vetoes Bill on Masks and Campaign Finance Reformby Mark Eisenberg 22.06.2024Gov. Roy Cooper vetoes bill banning public face masks and changing campaign finance laws, citing concerns over secret campaign money ...
Nesto Acquires CMLS Group, Expands Mortgage Servicesby Mark Eisenberg 22.06.2024Nesto acquires CMLS Group, merging to form a firm with 1,000+ employees managing $60B in mortgages. CEO Malik Yacoubi to ...
Monero Slides Over 4% in 24 Hours, Market Cap at $2.98Bby John Darbie 21.06.2024Monero's XMR price drops 4.47% in 24 hours to $162.05, continuing a week's negative trend. Trading volume tumbles 39%, market ...
Cooper Vetoes Controversial Bill on Protests and Campaign Financeby Mark Eisenberg 21.06.2024Gov. Cooper vetoes bill altering NC's campaign finance, protest penalties, and mask rules; sparks debate on billionaire influence in elections.
Zealand Pharma Surges on Promising Weight Loss Drug Trial Resultsby Mark Eisenberg 21.06.2024Zealand Pharma's stock surged 17% post-positive trial results for its weight loss drug, showing promising 8.6% average weight reduction. Analysts ...